Temasek-owned 65 Equity Partners has announced an investment in Swedish supercar maker Koenigsegg Automotive, taking its cumulative investments past the US$2 billion (about S$2.578 billion) milestone.
Founded in 1994 by Swedish automotive engineer Christian von Koenigsegg, Koenigsegg is an iconic Swedish supercar manufacturer headquartered in Ängelholm.
65 Equity Partners said on Thursday (19 November) that it had completed 19 investments globally since its establishment five years ago, with cumulative investments exceeding US$2 billion.
The firm, which specialises in supporting entrepreneur-led businesses and family-owned businesses, is expanding its investments in Europe. Koenigsegg is its fourth European investment in the past 24 months.
The firm described this as “reflecting the breadth of opportunities across the region and growing demand from successful entrepreneurs and family-owned businesses for long-term minority capital to support their growth ambitions”.
In a statement, 65 Equity Partners said it was providing fresh capital to support Koenigsegg’s next phase of growth and continued technological research and development, and to prepare it for a “potential future listing”. It did not disclose the investment amount.
The statement said Koenigsegg had become one of the world’s leading hypercar manufacturers, combining pioneering engineering and technological innovation with a globally renowned luxury brand. Koenigsegg has achieved exceptional growth in recent years, with average annual revenue growth of 80% since 2022 and an order backlog stretching more than three years ahead. Founder Christian von Koenigsegg will remain the controlling shareholder and continue to lead the company’s business development.
65 Equity Partners previously invested in French real estate project management consultancy Theop, which operates across several European markets, including France, Spain, Belgium and Italy.
65 Equity Partners has also invested in UK safety systems and solutions company Kee Safety, and partnered with Switzerland’s Braglia family to provide the first institutional capital to support the merger of HAS and Cerbios. The merger created a leading international pharmaceutical development and manufacturing group.
It said these four European investments reflected its minority investment strategy: partnering with outstanding businesses across industries, providing capital and strategic support for their ambitious growth plans while allowing existing shareholders to retain control.